Page last updated: 2024-09-04

ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and n,n-dimethyl-3,3-diphenyl-1-methylallylamine

ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination has been researched along with n,n-dimethyl-3,3-diphenyl-1-methylallylamine in 1 studies

Compound Research Comparison

Studies
(ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination)
Trials
(ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination)
Recent Studies (post-2010)
(ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination)
Studies
(n,n-dimethyl-3,3-diphenyl-1-methylallylamine)
Trials
(n,n-dimethyl-3,3-diphenyl-1-methylallylamine)
Recent Studies (post-2010) (n,n-dimethyl-3,3-diphenyl-1-methylallylamine)
2450610

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kjaer, M; Nielsen, H1

Other Studies

1 other study(ies) available for ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and n,n-dimethyl-3,3-diphenyl-1-methylallylamine

ArticleYear
Analgesic effect and bioavailability of oral ketogan given as tablets or mixture to patients with chronic pain of malignant origin.
    Acta oncologica (Stockholm, Sweden), 1988, Volume: 27, Issue:5

    Topics: Administration, Oral; Adult; Aged; Allylamine; Amines; Drug Combinations; Female; Half-Life; Humans; Male; Meperidine; Middle Aged; Neoplasms; Pain, Intractable; Tablets

1988